Pathway analysis using genome-wide association study data for coronary restenosis--a potential role for the PARVB gene

PLoS One. 2013 Aug 9;8(8):e70676. doi: 10.1371/journal.pone.0070676. eCollection 2013.

Abstract

Background: Coronary restenosis after percutaneous coronary intervention (PCI) still remains a significant limitation of the procedure. The causative mechanisms of restenosis have not yet been fully identified. The goal of the current study was to perform gene-set analysis of biological pathways related to inflammation, proliferation, vascular function and transcriptional regulation on coronary restenosis to identify novel genes and pathways related to this condition.

Methods: The GENetic DEterminants of Restenosis (GENDER) databank contains genotypic data of 556,099SNPs of 295 cases with restenosis and 571 matched controls. Fifty-four pathways, related to known restenosis-related processes, were selected. Gene-set analysis was performed using PLINK, GRASS and ALIGATOR software. Pathways with a p<0.01 were fine-mapped and significantly associated SNPs were analyzed in an independent replication cohort.

Results: Six pathways (cell-extracellular matrix (ECM) interactions pathway, IL2 signaling pathway, IL6 signaling pathway, platelet derived growth factor pathway, vitamin D receptor pathway and the mitochondria pathway) were significantly associated in one or two of the software packages. Two SNPs in the cell-ECM interactions pathway were replicated in an independent restenosis cohort. No replication was obtained for the other pathways.

Conclusion: With these results we demonstrate a potential role of the cell-ECM interactions pathway in the development of coronary restenosis. These findings contribute to the increasing knowledge of the genetic etiology of restenosis formation and could serve as a hypothesis-generating effort for further functional studies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actinin / genetics*
  • Actinin / metabolism
  • Aged
  • Case-Control Studies
  • Coronary Restenosis / genetics*
  • Coronary Restenosis / metabolism
  • Coronary Restenosis / pathology
  • Cytokines / genetics
  • Cytokines / metabolism
  • Endothelial Cells / metabolism*
  • Endothelial Cells / pathology
  • Endothelium, Vascular / metabolism*
  • Endothelium, Vascular / pathology
  • Extracellular Matrix / genetics
  • Extracellular Matrix / metabolism*
  • Extracellular Matrix / pathology
  • Female
  • Gene Expression Regulation
  • Genetic Predisposition to Disease*
  • Genome-Wide Association Study
  • Humans
  • Male
  • Metabolic Networks and Pathways
  • Middle Aged
  • Signal Transduction
  • Software

Substances

  • Cytokines
  • PARVB protein, human
  • Actinin

Grants and funding

This work was funded by grants from the Interuniversity Cardiology Institute of the Netherlands (ICIN) http://www.icin.nl/, the European Community Framework FP7 Programme under grant agreement [no HEALTH-F2-2009-223004], the Center for Medical Systems Biology (CMSB) [http://www.cmsb.nl], a center of excellence approved by the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (NWO), and the Netherlands Consortium for Healthy Ageing (NCHA) [http://www.healthy-ageing.nl]. JWJ is an established clinical investigator of the Netherlands Heart Foundation (2001D032) [http://www.hartstichting.nl/]. The funders had no role in study design, data collection and analysis, decision to publish or the preparation of the manuscript.